Artigo de periodico

Impact of CD34 cell dose and conditioning regimen on outcomes after haploidentical donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for relapsed/refractory severe aplastic anemia (2020)

• Authors:
  • Arcuri, Leonardo Javier
  • Nabhan, Samir Kanaan
  • Cunha, Renato Luiz Guerino
  • Nichele, Samantha
  • Ribeiro, Andreza Alice Feitosa
  • Fernandes, Juliana Folloni
  • Daudt, Liane Esteves
  • Rodrigues, Ana Luiza Melo
  • Arrais-Rodrigues, Celso
  • Seber, Adriana
  • Simões, Belinda Pinto
• USP affiliated authors: CUNHA, RENATO LUIZ GUERINO - FMRP ; SIMOES, BELINDA PINTO - FMRP
• Unidade: FMRP
• DOI: 10.1016/j.bbmt.2020.09.007
• Subjects: CÉLULAS-TRONCO; ANEMIA; DOADORES DE SANGUE; HEMATOLOGIA; TRANSPLANTE DE MEDULA ÓSSEA
• Keywords: Haploidentical; Aplastic anemia; Alternativo donors
• Language: Inglês
• Imprenta:
  • Publisher place: Philadelphia
  • Date published: 2020
• Source:
  • Título: Biology of Blood and Marrow Transplantation
  • ISSN: 1083-8791
  • Volume/Número/Paginação/Ano: v. 26, n. 12, p. 2311-2317, 2020

Informações sobre o DOI: 10.1016/j.bbmt.2020.09.007 (Fonte: oaDOI API)
• Este periódico é de acesso aberto
• Este artigo NÃO é de acesso aberto
  

---

Download do texto completo

Tipo	Nome	Link
	003124978.pdf	Direct link

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  ARCURI, Leonardo Javier et al. Impact of CD34 cell dose and conditioning regimen on outcomes after haploidentical donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for relapsed/refractory severe aplastic anemia. Biology of Blood and Marrow Transplantation, v. 26, n. 12, p. 2311-2317, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.bbmt.2020.09.007. Acesso em: 10 fev. 2026.

• APA

  Arcuri, L. J., Nabhan, S. K., Cunha, R. L. G., Nichele, S., Ribeiro, A. A. F., Fernandes, J. F., et al. (2020). Impact of CD34 cell dose and conditioning regimen on outcomes after haploidentical donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for relapsed/refractory severe aplastic anemia. Biology of Blood and Marrow Transplantation, 26( 12), 2311-2317. doi:10.1016/j.bbmt.2020.09.007

• NLM

  Arcuri LJ, Nabhan SK, Cunha RLG, Nichele S, Ribeiro AAF, Fernandes JF, Daudt LE, Rodrigues ALM, Arrais-Rodrigues C, Seber A, Simões BP. Impact of CD34 cell dose and conditioning regimen on outcomes after haploidentical donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for relapsed/refractory severe aplastic anemia [Internet]. Biology of Blood and Marrow Transplantation. 2020 ; 26( 12): 2311-2317.[citado 2026 fev. 10 ] Available from: https://doi.org/10.1016/j.bbmt.2020.09.007

• Vancouver

  Arcuri LJ, Nabhan SK, Cunha RLG, Nichele S, Ribeiro AAF, Fernandes JF, Daudt LE, Rodrigues ALM, Arrais-Rodrigues C, Seber A, Simões BP. Impact of CD34 cell dose and conditioning regimen on outcomes after haploidentical donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for relapsed/refractory severe aplastic anemia [Internet]. Biology of Blood and Marrow Transplantation. 2020 ; 26( 12): 2311-2317.[citado 2026 fev. 10 ] Available from: https://doi.org/10.1016/j.bbmt.2020.09.007

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• Outcomes of non-myeloablative HLA-haploidentical bone marrow transplant with thiotepa and post-transplant cyclophosphamide in children and adults with severe sickle cell disease, a phase ii trial: Vanderbilt global haploidentical transplant learning collaborative (VGC²)
• Associação prognóstica de polimorfismos gênicos da resposta imunológica em doadores e receptores de transplante não aparentado de células tronco hematopoiéticas de sangue de cordão umbilical e placentário
• The Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular seeks the implementation of, and access to, the CAR-T cell treatment in Brazil [Editorial]
• Haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide for severe aplastic anemia
• Autologous hematopoietic stem cell transplantation for Takayasu’s arteritis: report of three cases
• Esplenomegalia
• Invasive fungal diseases in haematopoietic cell transplant recipients and in patients with acute myeloid leukaemia or myelodysplasia in Brazil
• Risks, benefits, and therapeutic potential of hematopoietic stem cell transplantation for autoimmune diabetes
• Allogeneic hematopoietic stem cell transplantation (HSCT): EBMT risk score evaluation for chronic myeloid leukemia in Brazil
• Chronic itp patients respond poorly to high dose dexamethasone: a pilot study